🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this randomized clinical trial is to learn if topical treatment...
Status
Recruiting
Location
Genesis Cancer and Blood Institute
Start Date
2025-08-25
Trial ID
NCT06830863
Demonstrate the safety and efficacy of NB-001 in subjects with recurrent he...
Status
Completed
Location
Radiant Research, Inc
Start Date
2011-04
Trial ID
NCT01321359
Treatments Being Tested
To study the effect of fractionated 1927-nm non ablative thulium laser in r...
Status
Recruiting
Location
Henry Ford Medical Center
Start Date
2023-11-15
Trial ID
NCT06149780
Treatments Being Tested
The objectives of this study are to compare the safety of DFD01 Spray to Co...
Status
Completed
Location
Horizon Research Group, Inc.
Start Date
2013-11
Trial ID
NCT01947491
Treatments Being Tested
This is a randomized double-blind vehicle-controlled Phase 3 study to evalu...
Status
Completed
Location
Dermavant Investigative Site
Start Date
2019-06-06
Trial ID
NCT03983980
Treatments Being Tested
The purpose of this study is to confirm the clinical efficacy and the safet...
Status
Completed
Location
Site #102
Start Date
2016-08-02
Trial ID
NCT03004469
Treatments Being Tested
A Phase 2 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Ascen...
Status
Completed
Location
PPD 137
Start Date
2015-06-12
Trial ID
NCT02462187
Treatments Being Tested
Epidermolysis bullosa simplex (EBS) is a rare genetic skin disease characte...
Status
Terminated
Location
Phoenix Childrens Hospital
Start Date
2017-06-01
Trial ID
NCT03154333
Treatments Being Tested
The purpose of this study is to determine whether DRM02 is safe and effecti...
Status
Completed
Location
Clinique Médicale Dr Isabelle Delorme
Start Date
2013-10
Trial ID
NCT01993433
The purpose of this study is to assess the efficacy and safety of twice dai...
Status
Completed
Location
Cahaba Dermatology
Start Date
2018-12-20
Trial ID
NCT03745638
Treatments Being Tested